Rapid classification of a novel ALS-causing I149S variant in superoxide dismutase-1

Victoria K. Shephard,Mikayla L. Brown,Bryony A. Thompson,Alisha Harpur,Luke McAlary

DOI: https://doi.org/10.1080/21678421.2024.2351177

2024-05-16

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Abstract:Variants of the oxygen free radical scavenging enzyme superoxide dismutase-1 (SOD1) are associated with the neurodegenerative disease amyotrophic lateral sclerosis (ALS). These variants occur in roughly 20% of familial ALS cases, and 1% of sporadic ALS cases. Here, we identified a novel SOD1 variant in a patient in their 50s who presented with movement deficiencies and neuropsychiatric features. The variant was heterozygous and resulted in the isoleucine at position 149 being substituted with a serine (I149S). In silico analysis predicted the variant to be destabilizing to the SOD1 protein structure. Expression of the SOD1 I149S variant with a C-terminal EGFP tag in neuronal-like NSC-34 cells resulted in extensive inclusion formation and reduced cell viability. Immunoblotting revealed that the intramolecular disulphide between Cys57 and Cys146 was fully reduced for SOD1 I149S . Furthermore, SOD1 I149S was highly susceptible to proteolytic digestion, suggesting a large degree of instability to the protein fold. Finally, fluorescence correlation spectroscopy and native-PAGE of cell lysates showed that SOD1 I149S was monomeric in solution in comparison to the dimeric SOD1 WT . This experimental data was obtained within 3 months and resulted in the rapid re-classification of the variant from a variant of unknown significance (VUS) to a clinically actionable likely pathogenic variant.

clinical neurology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how to quickly and accurately classify a new ALS - causing mutation - the I149S variant in the SOD1 gene. Specifically, researchers discovered this new SOD1 variant in a patient in his/her 50s who showed movement disorders and neuropsychiatric features. To determine whether this variant is pathogenic, the research team conducted detailed molecular and biochemical analyses, including: 1. **Computational prediction**: The Aggrescan 2D tool was used to predict the effect of the I149S variant on the aggregation tendency of the SOD1 protein, and the MAESTRO server was used to predict the change in protein stability caused by this variant. 2. **Cell experiments**: The SOD1 I149S variant with a C - terminal EGFP tag was expressed in neuron - like NSC - 34 cells to observe its ability to form inclusion bodies and its impact on cell viability. 3. **Biochemical analysis**: The disulfide bond formation of the SOD1 I149S variant was detected by immunoblotting, its dimerization state was analyzed by fluorescence correlation spectroscopy (FCS) and native PAGE, and its structural stability was evaluated by protease K digestion experiments. Through these experiments, the research team completed a detailed analysis of this variant within less than three months and re - classified it from a "variant of uncertain significance" to a "possibly pathogenic variant". This rapid and accurate classification helps patients obtain a more definite diagnosis and may enter clinical trials more quickly to receive targeted treatment.

Rapid classification of a novel ALS-causing I149S variant in superoxide dismutase-1

Rapid classification of a novel ALS-causing I149S variant in superoxide dismutase-1

Comprehensive in silico analysis and molecular dynamics of the superoxide dismutase 1 (SOD1) variants related to amyotrophic lateral sclerosis

Missense Mutations of Codon 116 in the SOD1 Gene Cause Rapid Progressive Familial ALS and Predict Short Viability With PMA Phenotype

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

Pathogenicity Classification of SOD1 Variants of Uncertain Significance by in Vitro Aggregation Propensity

A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity

A Rare Cu/Zn Superoxide Dismutase Mutation Causing Familial Amyotrophic Lateral Sclerosis with Variable Age of Onset, Incomplete Penetrance and a Sensory Neuropathy

Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord

Clinical characterization of common pathogenic variants of SOD1-ALS in Germany

Clinical Features and Cu/Zn Superoxide Dismutase Gene Mutations in Two Mainland Chinese Families with Amyotrophic Lateral Sclerosis

A truncating SOD1 mutation, p.Gly141X, is associated with clinical and pathologic heterogeneity, including frontotemporal lobar degeneration

The G41D mutation in SOD1-related amyotrophic lateral sclerosis exhibits phenotypic heterogeneity among individuals: A case report and literature review

Evaluating protein cross-linking as a therapeutic strategy to stabilize SOD1 variants in a mouse model of familial ALS

Identification and Functional Analysis of Novel Mutations in the SOD1 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis.

SOD1 Mutation Spectrum and Natural History of ALS Patients in a 15-Year Cohort in Southeastern China

A novel 10-base pair insertion mutation in exon 5 of the SOD1 gene in a Chinese family with amyotrophic lateral sclerosis

Seeding activity of human superoxide dismutase 1 aggregates in familial and sporadic amyotrophic lateral sclerosis postmortem neural tissues by real-time quaking-induced conversion

The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration

Identification of a Novel Missense (C7W) Mutation of SOD1 in a Large Familial Amyotrophic Lateral Sclerosis Pedigree

Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions